Length rather than a specific allele of dinucleotide repeat in the 5' upstream region of the aldose reductase gene is associated with diabetic retinopathy

Diabetic Medicine

Volumn 16, Issue 12, 1999, Pages 1044-1047

  Fujisawa, T ^a   Ikegami, Hiroshi ^a,c   Kawaguchi, Y ^a   Yamato, E ^a   Nakagawa, Y ^a   Shen, G Q ^a   Fukuda, M ^b   Ogihara, T ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA POLICE HOSPITAL   (Japan)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Aldose reductase; Diabetic microangiopathy; Diabetic retinopathy; Dinucleotide repeat; Genetic susceptibility

Indexed keywords

ALDEHYDE REDUCTASE;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DINUCLEOTIDE REPEAT; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS;

AGED; ALDEHYDE REDUCTASE; ALLELES; DIABETIC RETINOPATHY; DINUCLEOTIDE REPEATS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED;

EID: 0033390623     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.1999.00192.x     Document Type: Article

References (28)

1. 1 Leslie RDG, Pyke DA. Diabetic retinopathy in identical twins. Diabetes 1982; 31: 19-21.
2. 2 Seaquist ER, Goetz FC, Rich S, Barbosa J. Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 1989; 320: 1161-1165.
3. 3 Raskin P. Risk factors for the development of diabetic complications. J Diabetes Complications 1994; 8: 195-200.
4. 4 Chowdhury TA, Kumar S, Barnett AH, Bain SC. Nephropathy in type 1 diabetes: the role of genetic factors. Diabet Med 1995; 12: 1059-1067.
5. 5 Rich SS, Freedman BI, Bowden DW. Genetic epidemiology of diabetic complications. Diabet Rev 1 997; 5: 165-173.
6. 6 Frank RN, The aldose reductase controversy. Diabetes 1994; 43: 169-172.
7. 7 Yamaoka T, Nishimura C, Yamashita K, Itakura M, Yamada T, Fujimoto J et al. Acute onset of diabetic pathological changes in transgenic mice with human aldose reductase. Diabetalogia 1995; 38: 255-261.
8. 8 Tomlinson D, Stevens F., Diemel L. Aldose reductase inhibitors and their potential for the treatment of diabetic complications. Trends Pharmacol Sci 1994; 15: 293-297.
9. 9 Hamada Y, Kitoh R, Raskin P. Association of erythrocyte aldose reductase activity with diabetic complications in type 1 diabetes mellitus. Diabet Med 1993; 10: 33-38.
10. 10 Nishimura C, Saito T, Ito T, Omori Y, Tanimoto T. High levels of erythrocyte aldose reductase and diabetic retinopathy in NIDDM patients. Diabetologia 1994; 37: 328-330.
11. 11 Pfeifer MA, Schumer MP, Gelber DA. Aldose reductase inhibitors: the end of an era or the need for different trial designs? Diabetes 1994; 46: S82-89.
12. 12 Ko BC-B, Lam KS-L, Wat NM-S, Chung SS-M. An (A-C) n dinucleotide repeat polymorphic marker at the 5′ end of the aldose reductase gene is associated with early-onset diabetic retinopathy in NIDDM patients. Diabetes 1995; 44: 727-732.
13. 13 Heesom AE, Hibberd ML, Millward A, Demaine AG. Polymorphism in the 5′-end of the aldose reductase gene is strongly associated with the development of diabetic nephropathy in type 1 diabetes. Diabetes 1997; 46: 287-291.
14. 14 Krolewski AS, Warram JH, Rand LI, Kahn CR. Epidemiologic approach to the etiology of type I diabetes mellitus and its complication. N Engl J Med 1987; 317: 1390-1398.
15. 15 Barbosa J, Saner B. Do genetic factors play a role in the pathogenesis of diabetic microangiopahty? Diabetologia 1984; 27: 487-492.
16. 16 Henry DN, Del Monte M, Greene DA, Killen PD. Altered aldose reductase gene regulation in cultured human retinal pigment epithelial cells. J Clin Invest 1993; 92: 617-623.
17. 17 Nishimura C, Hotta Y, Gui T, Seko A, Fujimaki T, Ishikawa T et al. The level of erythrocyte aldose reductase is associated with the severity of diabetic retinopathy. Diabet Res Clin Pract 1997; 37: 173-177.
18. 18 Imperatole G, Hanson RL, Petit DJ, Bennet PH, Knowler WC and the Pima Diabetes Gene Group. Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Diabetes 1998; 47: 821-830.
19. 19 Graham A, Heath P, Morten JE, Markham AF. The human aldose reductase gene maps to chromosome region 7q35. Hum Genet 1991; 86: 509-514.
20. 20 Timchenko LT, Caskey CT. Trinucleotide repeat disorders in humans: discussion of mechanism and medical issues. FASEB J 1996; 10: 1589-1597.
21. 21 Bennet ST, Lucassen AM, Gough SCL, Powel EE, Undlien DE, Pilchard LE et al. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nature Genet 1995; 9: 284-292.
22. 22 Kennedy GC, German MS, Rutter WJ. The minisatellite in the diabetes susceptibility locus IDDM2 regulates insulin transcription. Nature Genet 1995; 9: 293-298.
23. 23 Sutherland GR, Richards RI. Simple tandem DNA repeats and human genetic disease. Proc Natl Acad Sci USA 1995; 92: 363-3641.
24. 24 Vafiadis P, Bennet ST, Todd JA, Nadeau J, Grabs R, Goodyer CG et al. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nature Genet 1997; 15: 289-292.
25. 25 Pugliese A, Zeller M, Fernandez A Jr, Zalcberg LJ, Bartiett RJ, Ricordi C et al. The insulin gene is transcribed in the human thymus and transcription levels correlate with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nature Genet 1997; 15: 293-298.
26. 26 Wang K, Bohren KM, Gabby KH. Characterization of the human aldose reductase gene promoter. J Biol Chem 1993; 268: 16052-16058.
27. 27 Ruepp B, Bohren KM, Gabby KH. Characterization of the osmotic response element of the human aldose reductase gene promoter. Proc Natl Acad Sci USA 1996; 93: 8624-8629.
28. 28 Richard RI, Sutherland GR. Simple repeat DNA is not replicated simply. Nat Genet 1994; 6: 114-116.